Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.

Literature DB >> 18519722

In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.

Ellen S Moland¹, David W Craft, Seong-geun Hong, Soo-young Kim, Lucas Hachmeister, Shimon D Sayed, Kenneth S Thomson.

Abstract

Polymyxin B, minocycline, and tigecycline were the most potent of 10 antibiotics against 170 isolates of multidrug-resistant Acinetobacter baumannii. In time-kill studies, the exposure of a highly tigecycline-resistant isolate to tigecycline resulted in enhanced susceptibility to amikacin and synergistic bactericidal activities of the two drugs.

Entities: Chemical Species

Mesh：

Substances：

Year: 2008 PMID： 18519722 PMCID： PMC2493109 DOI： 10.1128/AAC.01581-07

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

1. Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.

Authors: D Milatovic; F-J Schmitz; J Verhoef; A C Fluit
Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191

2. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.

Authors: Jimmy Yoon; Carl Urban; Christian Terzian; Noriel Mariano; James J Rahal
Journal: Antimicrob Agents Chemother Date: 2004-03 Impact factor: 5.191

3. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

Authors: L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar
Journal: J Clin Microbiol Date: 2005-02 Impact factor: 5.948

Review 4. Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors: Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2007-07-23 Impact factor: 5.191

5. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.

Authors: Philip D Lister; Daniel J Wolter
Journal: Clin Infect Dis Date: 2005-02-15 Impact factor: 9.079

6. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

Authors: Helio S Sader; Ronald N Jones
Journal: Int J Antimicrob Agents Date: 2005-05 Impact factor: 5.283

7. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

Authors: V M Manikal; D Landman; G Saurina; E Oydna; H Lal; J Quale
Journal: Clin Infect Dis Date: 2000-07-17 Impact factor: 9.079

8. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.

Authors: Jana M Swenson; George E Killgore; Fred C Tenover
Journal: J Clin Microbiol Date: 2004-11 Impact factor: 5.948

9. Overview of nosocomial infections caused by gram-negative bacilli.

Authors: Robert Gaynes; Jonathan R Edwards
Journal: Clin Infect Dis Date: 2005-08-16 Impact factor: 9.079

10. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City.

Authors: John Quale; Simona Bratu; David Landman; Renuka Heddurshetti
Journal: Clin Infect Dis Date: 2003-07-09 Impact factor: 9.079

15 in total

1. In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Authors: C Silvestri; O Cirioni; D Arzeni; R Ghiselli; O Simonetti; F Orlando; G Ganzetti; S Staffolani; L Brescini; M Provinciali; A Offidani; M Guerrieri; A Giacometti
Journal: Eur J Clin Microbiol Infect Dis Date: 2011-12-11 Impact factor: 3.267

2. In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase.

Authors: Dora E Wiskirchen; Pornpan Koomanachai; Anthony M Nicasio; David P Nicolau; Joseph L Kuti
Journal: Antimicrob Agents Chemother Date: 2011-01-31 Impact factor: 5.191

3. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.

Authors: Jooyun Lee; Gopi Patel; Shirish Huprikar; David P Calfee; Stephen G Jenkins
Journal: J Clin Microbiol Date: 2009-03-04 Impact factor: 5.948

4. Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents.

Authors: Tingting Zhang; Min Wang; Yixin Xie; Xianping Li; Zhihui Dong; Yanhua Liu; Ling Wang; Min Yang; Huan Song; Hong Cao; Wei Cao
Journal: Exp Ther Med Date: 2017-02-21 Impact factor: 2.447

Review 5. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors: Ming-Feng Lin; Chung-Yu Lan
Journal: World J Clin Cases Date: 2014-12-16 Impact factor: 1.337

6. In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.

Authors: G P Neupane; D-M Kim
Journal: Eur J Clin Microbiol Infect Dis Date: 2010-02-02 Impact factor: 3.267